Holen Sie sich die Stockscreener-App
44.04
0.02%
0.010
Handel nachbörslich:
44.04
Schlusskurs vom Vortag:
$44.03
Offen:
$43.46
24-Stunden-Volumen:
446.15K
Relative Volume:
0.62
Marktkapitalisierung:
$1.54B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.85%
1M Leistung:
+28.14%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$42.41
$45.35
1-Wochen-Bereich:
$42.41
$49.91
52-Wochen-Spanne:
$14.72
$49.91
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Firmenname
First Tracks Biotherapeutics Inc
Sektor
Branche
Telefon
212-373-3000
Adresse
10770 WATERIDGE CIRCLE, SAN DIEGO
Compare TRAX vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
44.04 | 1.61B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-24 | Eingeleitet | Leerink Partners | Outperform |
| 2026-04-24 | Eingeleitet | Wedbush | Outperform |
| 2026-04-23 | Eingeleitet | JP Morgan | Overweight |
| 2026-04-22 | Eingeleitet | Barclays | Overweight |
| 2026-04-21 | Eingeleitet | UBS | Buy |
First Tracks Biotherapeutics Inc Aktie (TRAX) Neueste Nachrichten
AnaptysBio earnings ahead: First results as royalty company By Investing.com - Investing.com Australia
TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
First Tracks Biotherapeutics (NASDAQ: TRAX) Share Price, TRAX Stock News, TRAX Share Price & Updates - kalkine.ca
First Tracks Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $63.38, Implies 37% Upside - TradingView
Piper Sandler raises First Tracks stock price target on pipeline progress - Investing.com Australia
TRAX Maintained by First Tracks -- Price Target Raised to $95.00 - GuruFocus
First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results - Benzinga
A Quick Look at Today's Ratings for First Tracks Biotherapeutics(TRAX.US), With a Forecast Between $57 to $95 - Moomoo
TRAX Maintained by HC Wainwright & Co. -- Price Target Raised to $57.00 - GuruFocus
Wedbush Adjusts PT on First Tracks Biotherapeutics to $70 From $60, Maintains Outperform Rating - marketscreener.com
First Tracks Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $60.5, Implies 31% Upside - tradingview.com
TRAX SWOT Analysis: Clinical Pipeline and Financial Challenges R - GuruFocus
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:13 AM - Bitget
Form 8K FIRST TRACKS BIOTHERAPEUTICS For: 12 August By Investing.com - Investing.com South Africa
First Tracks Biotherapeutics 2Q 2026: Net loss $(33.4M), EPS $(0.95) — 10-Q Summary - TradingView
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
First Tracks Biotherapeutics (TRAX) details $83.9M loss and $168M cash after spin-off - Stock Titan
symbol__ Stock Quote Price and Forecast - cnn.com
First Tracks Biotherapeutics Ord Shs (TRAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
FMR LLC Acquires Stake in First Tracks Biotherapeutics Inc (TRAX): A Strategic Bet on Clinical-Stage Innovation - GuruFocus
UBS Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65 - Moomoo
UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating - Moomoo
First Tracks Biotherapeutics (TRAX) reports 16,667 performance stock units - Stock Titan
AnaptysBio earnings ahead: Can royalty revenue offset spinoff volatility? - Investing.com
AnaptysBio earnings ahead: Can royalty revenue offset spinoff volatility? By Investing.com - Investing.com Canada
First Tracks Biotherapeutics (TRAX) awards 60,492 performance stock units - Stock Titan
First Tracks Biotherapeutics (TRAX) awards 60,492 PSUs to CMO - Stock Titan
Biotech Stocks At 52-Week Highs- CORT +30%, NEOG +22% & BAX +7% With Quarterly Results, TRAX, XNCR - RTTNews
First Tracks Biotherapeutics Inc (TRAX) Gets a Buy from Wells Fargo - The Globe and Mail
Wells Fargo Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $55 - Moomoo
First Tracks Is Maintained at Overweight by Wells Fargo - Moomoo
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential - TipRanks
After Forte acquisition, H.C. Wainwright says First Tracks could be target - TipRanks
TRAX Stock Volatile As Traders Focus On Cash And Momentum - StocksToTrade
Wedbush Adjusts First Tracks Biotherapeutics Price Target to $60 From $30, Maintains Outperform Rating - marketscreener.com
Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
These stocks that are showing activity before the opening bell on Monday. - ChartMill
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Anaptysbio, Inc Net Worth (2026) - GuruFocus
Which stocks are moving before the opening bell on Thursday? - ChartMill
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $54 - Moomoo
TRAX Stock Hits All-Time High — What's Driving The Super Rally? - Stocktwits
First Tracks Biotherapeutics (TRAX) Stock Forum and Discussion - Moomoo
First Tracks Biotherapeutics Inc. (TRAX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
First Tracks Biotherapeutics (TRAX) News Flow - Moomoo
Analysts Offer Insights on NA Companies: Fervo Energy Company Class A (FRVO) and First Tracks Biotherapeutics Inc (TRAX) - The Globe and Mail
XPEV Stock Rises 1.5% As CEO Takes First Robotaxi Ride In Guangzhou - Stocktwits
Meta, Moderna among market cap stock movers on Friday By Investing.com - Investing.com Australia
TRAX Stock Surges As Traders Pile Into Biotech Momentum - timothysykes.com
Lithium Americas Corp. (LAC) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Finanzdaten der First Tracks Biotherapeutics Inc-Aktie (TRAX)
Es liegen keine Finanzdaten für First Tracks Biotherapeutics Inc (TRAX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):